Coxibs - Past Problems...Future Potential

Title	Published	Price
Snapshots US Pharmaceuticals 2009 By: Snapdata International Group Snapdata's Snapshots US Pharmaceuticals 2009 provides 2008 year-end market size data, with 2009 estimates, 5 years of historical data and five-year forecasts. The Snapshots report gives an instant overview of the US pharmaceutical market and \| more... Search inside this report	11/12/2009	$600.00
Asia Pacific Pharma Sector Analysis By: RNCOS The world continues to witness significant shift in the global pharmaceutical market landscape, with Asia-Pacific emerging as the fastest growing pharmaceutical market over the recent past. With low costs and favorable regulatory environment, the region \| more...	11/1/2009	$1,200.00
Pharmaceuticals Industry Report By: Plimsoll Publishing Ltd. The Global Pharmaceuticals Industry Report Plimsoll Publishing Ltd. Do you know.... The top 7 best trading partners in the industry? Which company has the highest sales growth? Which companies have the highest levels of debt? This report is an in-depth financial \| more...	11/1/2009	$1,500.00
BI for Drug Development: Oracle Introduces Clinical Development Analytics By: IDC This IDC Health Insights Perspective highlights the announcement of a dedicated life science business intelligence (BI) solution introduced recently at Oracle OpenWorld 2009 that promises to deliver actionable insights into clinical development processes. Oracle Clinical \| more... Search inside this report	11/1/2009	$1,500.00
Antipsychotics Market Forecast By: Datamonitor Introduction In 2008, seven major market sales of antipsychotics reached $18.2 billion. Datamonitor forecasts the market value to peak in 2011 when it will then succumb to generic erosion, particularly in the US where incursion is \| more...	10/28/2009	$15,200.00
Pipeline Insight: Colorectal Cancer - Growing trend towards personalized medicine By: Datamonitor Introduction CRC incidence will be over 490,000 cases by 2018 in the seven major markets. This large patient base will translate into a high commercial potential for the development of novel, more effective therapies. Currently, there \| more...	10/21/2009	$11,400.00
Commercial Insight: Antidiabetics in Australia - Reimbursement status shapes novel classes By: Datamonitor Introduction Datamonitor expects the Australian antidiabetics market to reach $416m by 2018. The growth will be driven by the launch of new drug classes, notably the incretin mimetics, and large growth in patient numbers. Although strongest \| more...	10/20/2009	$5,700.00
Notable News in the Life Sciences: 3Q09 By: IDC This Health Industry Insights Perspective provides an unranked list and assessment of important news and trends reported in July through September 2009. (Note also that progress attained or subsequent news reported after the initial announcement \| more... Search inside this report	10/18/2009	$1,500.00
Prescription Drug Wholesaling in the US - Industry Risk Rating Report By: IBISWorld Industry Risk Ratings Synopsis This Industry Risk Ratings report from IBISWorld evaluates the inherent risks associated with the Prescription Drug Wholesaling in the US industry. Industry Risk is assumed to be 'the difficulty, or otherwise, of \| more... Search inside this report	10/17/2009	$825.00
Pharmaceuticals Wholesaling in Australia - Industry Risk Rating Report By: IBISWorld Industry Risk Ratings Synopsis This Industry Risk Ratings report from IBISWorld evaluates the inherent risks associated with the Pharmaceuticals Wholesaling in Australia industry. Industry Risk is assumed to be 'the difficulty, or otherwise, of the business \| more... Search inside this report	10/17/2009	$810.00

Phone: 800.298.5699 (US) or +1.240.747.3093 (Int'l)
Hours: 7:00 a.m. to 7:00 p.m. EST Monday through Friday
Email: customerservice@marketresearch.com
Copyright © 1999-2009, All Rights Reserved, MarketResearch.com
11/22/2009 - 3